The lung immune prognostic index as a predictive biomarker in urological malignancies undergoing immune checkpoint inhibitor therapy

Objective We conducted a meta-analysis to evaluate the prognostic utility of the Lung Immune Prognostic Index (LIPI) in patients with urological malignancies treated with immune checkpoint inhibitors (ICIs).Methods We systematically searched PubMed, the Cochrane Library, and EMBASE up to March 3, 20...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Yan He, Yuan Yuan, Xiao Wei, Lili Li, Pengcheng Luo
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Taylor & Francis Group 2025-12-01
Cyfres:	Annals of Medicine
Pynciau:	Lung Immune Prognostic index (LIPI) immune checkpoint inhibitors (ICIs) urological malignancies meta-analyses
Mynediad Ar-lein:	https://www.tandfonline.com/doi/10.1080/07853890.2025.2582907
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!